Squarepoint’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$333K Sell
3,214
-171,819
-98% -$19.5M ﹤0.01% 3628
2025
Q4
$17.6M Sell
175,033
-187,224
-52% -$20.3M 0.02% 797
2025
Q3
$44.7M Sell
362,257
-81,430
-18% -$10.1M 0.04% 442
2025
Q2
$53.3M Sell
443,687
-252,251
-36% -$33.7M 0.06% 386
2025
Q1
$102M Buy
695,938
+126,028
+22% +$19.2M 0.12% 149
2024
Q4
$92.6M Buy
569,910
+206,249
+57% +$33.7M 0.09% 209
2024
Q3
$59.2M Buy
363,661
+133,922
+58% +$19.8M 0.09% 202
2024
Q2
$31.4M Buy
229,739
+136,164
+146% +$18.9M 0.05% 394
2024
Q1
$14.3M Buy
93,575
+42,535
+83% +$6.35M 0.02% 784
2023
Q4
$7.28M Sell
51,040
-199,504
-80% -$26.6M 0.01% 1143
2023
Q3
$32.8M Sell
250,544
-235,425
-48% -$35.8M 0.08% 276
2023
Q2
$77.3M Sell
485,969
-69,129
-12% -$11.2M 0.24% 71
2023
Q1
$87.8M Buy
555,098
+451,760
+437% +$67.7M 0.36% 32
2022
Q4
$14.5M Sell
103,338
-361,576
-78% -$51.3M 0.06% 362
2022
Q3
$59.7M Sell
464,914
-21,548
-4% -$3.11M 0.3% 47
2022
Q2
$68.6M Buy
486,462
+386,055
+384% +$55.2M 0.38% 47
2022
Q1
$14M Sell
100,407
-182,170
-64% -$27.9M 0.06% 349
2021
Q4
$49.3M Sell
282,577
-36,174
-11% -$6.03M 0.13% 132
2021
Q3
$52.8M Buy
318,751
+203,776
+177% +$35.1M 0.15% 130
2021
Q2
$20.7M Buy
114,975
+33,326
+41% +$6.08M 0.08% 229
2021
Q1
$15.7M Sell
81,649
-188,429
-70% -$36.3M 0.09% 228
2020
Q4
$54.5M Buy
270,078
+224,647
+494% +$46.5M 0.41% 27
2020
Q3
$9.55M Sell
45,431
-31,061
-41% -$6.92M 0.13% 187
2020
Q2
$16.8M Buy
76,492
+69,885
+1,058% +$14M 0.27% 81
2020
Q1
$1.15M Sell
6,607
-118,476
-95% -$19.6M 0.03% 668
2019
Q4
$19.2M Sell
125,083
-160,593
-56% -$24M 0.11% 154
2019
Q3
$43.4M Buy
285,676
+267,546
+1,476% +$42.3M 0.39% 39
2019
Q2
$2.78M Buy
18,130
+11,474
+172% +$1.75M 0.03% 676
2019
Q1
$1.07M Buy
+6,656
New +$1.03M 0.01% 1076
2017
Q4
Sell
-34,607
Closed -$4.57M 2111
2017
Q3
$4.57M Buy
34,607
+22,186
+179% +$2.98M 0.09% 295
2017
Q2
$1.66M Sell
12,421
-764
-6% -$103K 0.03% 574
2017
Q1
$1.78M Buy
+13,185
New +$1.71M 0.05% 422
2016
Q4
Sell
-6,508
Closed -$815K 1785
2016
Q3
$815K Sell
6,508
-444
-6% -$58.2K 0.05% 402
2016
Q2
$962K Sell
6,952
-9,631
-58% -$1.25M 0.06% 361
2016
Q1
$2.09M Buy
16,583
+14,487
+691% +$1.84M 0.16% 164
2015
Q4
$266K Sell
2,096
-23,493
-92% -$2.92M 0.03% 856
2015
Q3
$2.96M Buy
25,589
+22,858
+837% +$2.57M 0.74% 33
2015
Q2
$284K Buy
+2,731
New +$295K 0.09% 307

Other funds holding CLX

Squarepoint's CLX Position: Q1 2026 in Review

Squarepoint reduced its Clorox (CLX) stake by 98% in Q1 2026, selling an estimated $19.5M and leaving 3,214 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #3628.

Squarepoint first reported a position in CLX in Q2 2015 and has held it in 38 quarters since. The position peaked at $102M in Q1 2025. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Squarepoint held 3,214 shares of Clorox worth $333K as of Q1 2026.
  • Squarepoint sold 171,819 Clorox shares in Q1 2026, an estimated $19.5M.
  • Clorox made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3628 holding.
  • Squarepoint first reported a position in Clorox in Q2 2015 and has held it in 38 quarters since.
  • Squarepoint's Clorox position peaked at $102M in Q1 2025.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.